FR2515177A1 - Nouveaux derives de 1-(aminophenyl)-2-amino-1-ethanol, leur procede de preparation et leur utilisation en therapeutique - Google Patents

Nouveaux derives de 1-(aminophenyl)-2-amino-1-ethanol, leur procede de preparation et leur utilisation en therapeutique Download PDF

Info

Publication number
FR2515177A1
FR2515177A1 FR8120249A FR8120249A FR2515177A1 FR 2515177 A1 FR2515177 A1 FR 2515177A1 FR 8120249 A FR8120249 A FR 8120249A FR 8120249 A FR8120249 A FR 8120249A FR 2515177 A1 FR2515177 A1 FR 2515177A1
Authority
FR
France
Prior art keywords
sep
amino
ethanol
crl
chlorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8120249A
Other languages
English (en)
French (fr)
Other versions
FR2515177B1 (enExample
Inventor
Louis Lafon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Priority to FR8120249A priority Critical patent/FR2515177A1/fr
Publication of FR2515177A1 publication Critical patent/FR2515177A1/fr
Application granted granted Critical
Publication of FR2515177B1 publication Critical patent/FR2515177B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/26Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups and being further substituted by halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/56Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
    • C07C215/58Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C07C215/60Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/64Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • C07C217/66Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain
    • C07C217/70Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13Dicarboxylic acids
    • C07C57/15Fumaric acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR8120249A 1981-10-28 1981-10-28 Nouveaux derives de 1-(aminophenyl)-2-amino-1-ethanol, leur procede de preparation et leur utilisation en therapeutique Granted FR2515177A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8120249A FR2515177A1 (fr) 1981-10-28 1981-10-28 Nouveaux derives de 1-(aminophenyl)-2-amino-1-ethanol, leur procede de preparation et leur utilisation en therapeutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8120249A FR2515177A1 (fr) 1981-10-28 1981-10-28 Nouveaux derives de 1-(aminophenyl)-2-amino-1-ethanol, leur procede de preparation et leur utilisation en therapeutique

Publications (2)

Publication Number Publication Date
FR2515177A1 true FR2515177A1 (fr) 1983-04-29
FR2515177B1 FR2515177B1 (enExample) 1984-10-12

Family

ID=9263492

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8120249A Granted FR2515177A1 (fr) 1981-10-28 1981-10-28 Nouveaux derives de 1-(aminophenyl)-2-amino-1-ethanol, leur procede de preparation et leur utilisation en therapeutique

Country Status (1)

Country Link
FR (1) FR2515177A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146738A3 (en) * 1983-12-23 1987-07-29 American Cyanamid Company Antimicrobial animal feed additive compositions
WO2001017962A1 (en) * 1999-09-03 2001-03-15 Asahi Kasei Kabushiki Kaisha Processes for the preparation of tricyclic amino alcohol derivatives
CN110143886A (zh) * 2019-05-10 2019-08-20 北京化工大学 制备如妥洛特罗、氯丙那林、二氯异丙肾上腺素和索他洛尔的β-芳基氨基醇类药物的方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1561863A (enExample) * 1967-05-09 1969-03-28
FR2210414A1 (enExample) * 1972-12-18 1974-07-12 Thomae Gmbh Dr K
JPS5363333A (en) * 1976-11-12 1978-06-06 Hokuriku Pharmaceutical Nitro grouppsubstituted 22chlorobenzylalcohol derivative and process for preparing same
JPS5363332A (en) * 1976-11-12 1978-06-06 Hokuriku Pharmaceutical Amino grouppsubstituted 22chlorobenzylalcohol derivative and process for preparing same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1561863A (enExample) * 1967-05-09 1969-03-28
FR2210414A1 (enExample) * 1972-12-18 1974-07-12 Thomae Gmbh Dr K
JPS5363333A (en) * 1976-11-12 1978-06-06 Hokuriku Pharmaceutical Nitro grouppsubstituted 22chlorobenzylalcohol derivative and process for preparing same
JPS5363332A (en) * 1976-11-12 1978-06-06 Hokuriku Pharmaceutical Amino grouppsubstituted 22chlorobenzylalcohol derivative and process for preparing same

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CA1953 *
CA1968 *
CA1978 *
EXBK/72 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146738A3 (en) * 1983-12-23 1987-07-29 American Cyanamid Company Antimicrobial animal feed additive compositions
WO2001017962A1 (en) * 1999-09-03 2001-03-15 Asahi Kasei Kabushiki Kaisha Processes for the preparation of tricyclic amino alcohol derivatives
US6696573B1 (en) 1999-09-03 2004-02-24 Asahi Kasei Kabushiki Kaisha Processes for the preparation of tricyclic amino alcohol derivatives
CN110143886A (zh) * 2019-05-10 2019-08-20 北京化工大学 制备如妥洛特罗、氯丙那林、二氯异丙肾上腺素和索他洛尔的β-芳基氨基醇类药物的方法
CN110143886B (zh) * 2019-05-10 2022-11-01 北京化工大学 制备如妥洛特罗、氯丙那林、二氯异丙肾上腺素和索他洛尔的β-芳基氨基醇类药物的方法

Also Published As

Publication number Publication date
FR2515177B1 (enExample) 1984-10-12

Similar Documents

Publication Publication Date Title
EP0097071B1 (fr) Dérivés de benzhydrylsulfinylacétamide et leur utilisation en thérapeutique
EP0192521B1 (fr) Dérivés de 3-phényl-tétrahydropyridine, procédé de préparation et utilisation en thérapeutique
EP0097547B1 (fr) Acides halogénobenzhydrylsulfinylacétohydroxamiques, procédé de préparation et utilisation en thérapeutique
FR2511366A1 (fr) Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
CH619935A5 (enExample)
FR2534915A1 (fr) Nouveaux derives de 2-(phenoxymethyl)-morpholine, utilisation en therapeutique et procede de preparation
FR2515177A1 (fr) Nouveaux derives de 1-(aminophenyl)-2-amino-1-ethanol, leur procede de preparation et leur utilisation en therapeutique
EP0061406B1 (fr) Dérivés d'acide benzamido-alkyl-hydroxamique, procédé de préparation et composition thérapeutique
FR2625502A1 (fr) Nouveaux derives du 3-piperidine carbaldehyde oxime, leur procede de preparation et leur application comme medicaments
CH622795A5 (enExample)
EP0138716B1 (fr) Nouveaux dérivés de 2-tolyl-morpholine utiles en thérapeutique
EP0143711B1 (fr) Dérivés de N-(méthoxyphénacyl)-amine, utilisation notamment en thérapeutique et procédé de préparation
FR2486074A1 (fr) Derives de fluorophenacyl-amine, leur procede de preparation et leur application en therapeutique
FR2517305A1 (fr) Nouveaux derives de 2-phenyl-morpholine et leur utilisation en therapeutique
EP0097546B1 (fr) Benzhydrylsulfinyléthylamines, procédé de préparation et utilisation en thérapeutique
EP0158545B1 (fr) Dérivés d'acide [alpha-(alkylaminométhyl)-benzylthio]-acétique, procédé de préparation et utilisation en thérapeutique
EP0138715B1 (fr) Dérivés de N-(4-acétylaminophénacyl)-amine, leur utilisation en thérapeutique et leur procédé de préparation
CA1063619A (fr) Procede de preparation de nouveaux acides benzylamino alcanoiques et les produits qui en resultent
FR2460668A1 (fr) Derives de 2-amino-1-phenyl-1-ethanol, utiles en tant que medicaments et leur procede de preparation
FR2553411A1 (fr) Derives de 2-halogenophenyl-morpholine, procede de preparation et utilisation en therapeutique
EP0060954B1 (fr) Dérivés de fluorophénacyl-amine, et leur application en thérapeutique
EP0174887B1 (fr) Dérivés de 1-[N-(alpha-amino-alpha-méthylacétyl)-aminophényl]-2-amino-propanone, procédé de préparation et utilisation en thérapeutique
BE874322R (fr) Nouveaux composes heterocycliques, leur preparation et leur application comme medicaments
FR2946344A1 (fr) Nouveaux derives d'aryl-{4-halogeno-4-[aminomethyl]-piperidin-1-yl} methanone, leur procede de preparation et leur utilisation a titre de medicaments
FR2553412A1 (fr) Derives de 4-alkyl-2-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse